Glaucoma Medication and Quality of Life after Phacoemulsification Combined with a Xen Gel Stent
Glaucoma has a significant impact on quality of life. Here, we aimed to evaluate the influence of a reduction in glaucoma medications on quality of life and patient satisfaction after phacoemulsification combined with the Xen gel stent. We carried out a cross-sectional survey of patients who underwe...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2022-06-01
|
| Series: | Journal of Clinical Medicine |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2077-0383/11/12/3450 |
| _version_ | 1797485980664463360 |
|---|---|
| author | Christian Pahljina Stephanie Sarny Lukas Hoeflechner Thomas Falb Gernot Schliessleder Marlene Lindner Domagoj Ivastinovic Kaweh Mansouri Ewald Lindner |
| author_facet | Christian Pahljina Stephanie Sarny Lukas Hoeflechner Thomas Falb Gernot Schliessleder Marlene Lindner Domagoj Ivastinovic Kaweh Mansouri Ewald Lindner |
| author_sort | Christian Pahljina |
| collection | DOAJ |
| description | Glaucoma has a significant impact on quality of life. Here, we aimed to evaluate the influence of a reduction in glaucoma medications on quality of life and patient satisfaction after phacoemulsification combined with the Xen gel stent. We carried out a cross-sectional survey of patients who underwent phacoemulsification with the Xen gel stent at the Medical University of Graz, Austria. Quality of life was assessed using the German version of the Glaucoma Symptoms Scale (GSS)—questionnaire. Patients were also asked whether the operation reduced glaucoma medications and to indicate their overall satisfaction from 1 (totally discontented) up to 10 (totally contented). Questionnaires of 80 patients were evaluated. A total of 36 patients (45.0%) reported a reduction in glaucoma medications. Three items of the GSS were significantly better in patients who needed fewer glaucoma medications after the operation (“hard to see in daylight”, 75.0 ± 31.1 vs. 57.7 ± 39.1, <i>p</i> = 0.035; “hard to see in dark places”, 81.1 ± 28.7 vs. 54.9 ± 41.2, <i>p</i> = 0.002; and “halos around lights”, 88.3 ± 25.9 vs. 68.8 ± 38.6, <i>p</i> = 0.002). Patient satisfaction was significantly higher when the procedure led to a reduction in glaucoma medication (8.3 ± 2.0 vs. 6.8 ± 3.1; <i>p</i> = 0.034). The reported quality of life and patient satisfaction were significantly better when phacoemulsification with the Xen gel stent reduced the number of glaucoma medications needed. |
| first_indexed | 2024-03-09T23:27:34Z |
| format | Article |
| id | doaj.art-b205b513aa6c422ea05149c8f3c57bac |
| institution | Directory Open Access Journal |
| issn | 2077-0383 |
| language | English |
| last_indexed | 2024-03-09T23:27:34Z |
| publishDate | 2022-06-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Journal of Clinical Medicine |
| spelling | doaj.art-b205b513aa6c422ea05149c8f3c57bac2023-11-23T17:16:12ZengMDPI AGJournal of Clinical Medicine2077-03832022-06-011112345010.3390/jcm11123450Glaucoma Medication and Quality of Life after Phacoemulsification Combined with a Xen Gel StentChristian Pahljina0Stephanie Sarny1Lukas Hoeflechner2Thomas Falb3Gernot Schliessleder4Marlene Lindner5Domagoj Ivastinovic6Kaweh Mansouri7Ewald Lindner8Department of Ophthalmology, Medical University Graz, 8036 Graz, AustriaDepartment of Ophthalmology, Medical University Graz, 8036 Graz, AustriaDepartment of Ophthalmology, Medical University Graz, 8036 Graz, AustriaDepartment of Ophthalmology, Medical University Graz, 8036 Graz, AustriaDepartment of Ophthalmology, Medical University Graz, 8036 Graz, AustriaDepartment of Dentistry, Medical University Graz, 8036 Graz, AustriaDepartment of Ophthalmology, Medical University Graz, 8036 Graz, AustriaGlaucoma Research Center, Montchoisi Clinic, Swiss Visio, 1006 Lausanne, SwitzerlandDepartment of Ophthalmology, Medical University Graz, 8036 Graz, AustriaGlaucoma has a significant impact on quality of life. Here, we aimed to evaluate the influence of a reduction in glaucoma medications on quality of life and patient satisfaction after phacoemulsification combined with the Xen gel stent. We carried out a cross-sectional survey of patients who underwent phacoemulsification with the Xen gel stent at the Medical University of Graz, Austria. Quality of life was assessed using the German version of the Glaucoma Symptoms Scale (GSS)—questionnaire. Patients were also asked whether the operation reduced glaucoma medications and to indicate their overall satisfaction from 1 (totally discontented) up to 10 (totally contented). Questionnaires of 80 patients were evaluated. A total of 36 patients (45.0%) reported a reduction in glaucoma medications. Three items of the GSS were significantly better in patients who needed fewer glaucoma medications after the operation (“hard to see in daylight”, 75.0 ± 31.1 vs. 57.7 ± 39.1, <i>p</i> = 0.035; “hard to see in dark places”, 81.1 ± 28.7 vs. 54.9 ± 41.2, <i>p</i> = 0.002; and “halos around lights”, 88.3 ± 25.9 vs. 68.8 ± 38.6, <i>p</i> = 0.002). Patient satisfaction was significantly higher when the procedure led to a reduction in glaucoma medication (8.3 ± 2.0 vs. 6.8 ± 3.1; <i>p</i> = 0.034). The reported quality of life and patient satisfaction were significantly better when phacoemulsification with the Xen gel stent reduced the number of glaucoma medications needed.https://www.mdpi.com/2077-0383/11/12/3450glaucomaquality of lifesurveys and questionnairesminimal invasive glaucoma surgeryXen gel stent |
| spellingShingle | Christian Pahljina Stephanie Sarny Lukas Hoeflechner Thomas Falb Gernot Schliessleder Marlene Lindner Domagoj Ivastinovic Kaweh Mansouri Ewald Lindner Glaucoma Medication and Quality of Life after Phacoemulsification Combined with a Xen Gel Stent Journal of Clinical Medicine glaucoma quality of life surveys and questionnaires minimal invasive glaucoma surgery Xen gel stent |
| title | Glaucoma Medication and Quality of Life after Phacoemulsification Combined with a Xen Gel Stent |
| title_full | Glaucoma Medication and Quality of Life after Phacoemulsification Combined with a Xen Gel Stent |
| title_fullStr | Glaucoma Medication and Quality of Life after Phacoemulsification Combined with a Xen Gel Stent |
| title_full_unstemmed | Glaucoma Medication and Quality of Life after Phacoemulsification Combined with a Xen Gel Stent |
| title_short | Glaucoma Medication and Quality of Life after Phacoemulsification Combined with a Xen Gel Stent |
| title_sort | glaucoma medication and quality of life after phacoemulsification combined with a xen gel stent |
| topic | glaucoma quality of life surveys and questionnaires minimal invasive glaucoma surgery Xen gel stent |
| url | https://www.mdpi.com/2077-0383/11/12/3450 |
| work_keys_str_mv | AT christianpahljina glaucomamedicationandqualityoflifeafterphacoemulsificationcombinedwithaxengelstent AT stephaniesarny glaucomamedicationandqualityoflifeafterphacoemulsificationcombinedwithaxengelstent AT lukashoeflechner glaucomamedicationandqualityoflifeafterphacoemulsificationcombinedwithaxengelstent AT thomasfalb glaucomamedicationandqualityoflifeafterphacoemulsificationcombinedwithaxengelstent AT gernotschliessleder glaucomamedicationandqualityoflifeafterphacoemulsificationcombinedwithaxengelstent AT marlenelindner glaucomamedicationandqualityoflifeafterphacoemulsificationcombinedwithaxengelstent AT domagojivastinovic glaucomamedicationandqualityoflifeafterphacoemulsificationcombinedwithaxengelstent AT kawehmansouri glaucomamedicationandqualityoflifeafterphacoemulsificationcombinedwithaxengelstent AT ewaldlindner glaucomamedicationandqualityoflifeafterphacoemulsificationcombinedwithaxengelstent |